MindMaze Therapeutics Holding SA annual return on equity
2022
2023
MindMaze Therapeutics Holding SA Return on Equity (ROE) Growth & History (MMTZF)
MindMaze Therapeutics Holding SA's return on equity was −99.35% for fiscal 2023.
View full MindMaze Therapeutics Holding SA company overviewMindMaze Therapeutics Holding SA annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −99.35% | −68.28 pp |
| 2022 | 2022-12-31 | −31.07% | — |
MindMaze Therapeutics Holding SA return on equity trends
Between the periods ended 2022-12-31 and 2023-12-31, MindMaze Therapeutics Holding SA's return on equity decreased from −31.07% to −99.35%, a change of −68.28 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MindMaze Therapeutics Holding SA source filings ↗